ADiTxT Therapeutics Files for $25 Million IPO

On 1/15/2020 ADiTxt filed the paperwork for their $25 Million IPO. The offering will consist of common stock and warrants. The Loma Linda, CA based company is focused on developing treatments that prolong life and enhance life quality of transplant patients. The company intends to trade on NASDAQ  under the symbol “ADTX."